2019's sec­ond uni­corn Gos­samer rais­es $276M in up­sized IPO of­fer­ing, MP­M's Har­poon makes its Nas­daq de­but with $75.6M boun­ty

Meet 2019’s newest biotech uni­corn — Gos­samer Bio — which is mak­ing its de­but on Nas­daq Fri­day with an up­sized $276 mil­lion of­fer­ing.

The drug de­vel­op­er — with a val­u­a­tion of $1 bil­lion, ac­cord­ing to Re­nais­sance Cap­i­tal — is run by for­mer Re­cep­tos ex­ec­u­tives, and fol­lows the year’s first uni­corn Alec­tor $ALEC that raised $176 mil­lion at a $19 mid­point price. In­vestors are ea­ger­ly an­tic­i­pat­ing the per­for­mance of both, with an eye on oth­er IPO’s wait­ing in line, af­ter a tur­bu­lent De­cem­ber rav­aged stocks across the board, in­clud­ing Mod­er­na $MR­NA that saw a third of its colos­sus $7.5 bil­lion val­u­a­tion evap­o­rate soon af­ter its keen­ly watched mar­ket de­but.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER